The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Propofol Treatment of Refractory Status Epilepticus: A Study of 31 Episodes
Abstract
Summary: Purpose: Refractory status epilepticus (RSE) is a critical medical condition with high mortality. Although propofol (PRO) is considered an alternative treatment to barbiturates for the management of RSE, only limited data are available. The aim of this study was to assess PRO effectiveness in patients with RSE. Methods: We retrospectively considered all consecutive patients with RSE admitted to the medical intensive care unit (ICU) between 1997 and 2002 treated with PRO for induction of EEG‐monitored burst suppression. Subjects with anoxic encephalopathy showing pathological N20 on somatosensory evoked potentials were excluded. Results: We studied 31 RSE episodes in 27 adults (16 men, 11 women; median age, 41.5 years). All patients received PRO, and six also subsequently thiopental (THP). Clonazepam (CZP) was administered with PRO, and other antiepileptic drugs (AEDs) concomitant with PRO and THP. RSE was successfully treated with PRO in 21 (67%) episodes and with THP after PRO in three (10%). Median PRO injection rate was 4.8 mg/kg/h (range, 2.1–13), median duration of PRO treatment was 3 days (range, 1–9), and median duration of ICU stay was 7 days (range, 2–42). In 24 episodes in which the patient survived, shivering after general anesthesia was seen in 10 episodes, transient dystonia and hyperlipemia in one each, and mild neuropsychological impairment in five. The seven deaths were not directly related to PRO use. Conclusions: PRO administered with CZP was effective in controlling most of RSE episodes, without major adverse effects. In this setting, PRO may therefore represent a valuable alternative to barbiturates. A randomized trial with these drug classes could definitively assess their respective role in RSE treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
It’s time to revise the definition of status epilepticus
Lowenstein, D. H., Bleck, T., & Macdonald, R. L. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02000.x · Cited by 805
Cited by
Guidelines for the Evaluation and Management of Status Epilepticus
Neurocritical Care Society Status Epilepticus Guideline Writing Committee, Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., Glauser, T., LaRoche, S. M., Riviello, J. J., Shutter, L., et al. (2012) · Neurocritical Care · doi:10.1007/s12028-012-9695-z · Cited by 1,623
Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures
Purdon, P. L., Sampson, A., Pavone, K. J., & Brown, E. N. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000841 · Cited by 854
Shorvon, S., & Ferlisi, M. (2012) · Brain · doi:10.1093/brain/aws091 · Cited by 418
Refractory Status Epilepticus: Effect of Treatment Aggressiveness on Prognosis
Rossetti, A. O., Logroscino, G., & Bromfield, E. B. (2005) · Archives of Neurology · doi:10.1001/archneur.62.11.1698 · Cited by 341
Self-citationManagement of refractory status epilepticus in adults: still more questions than answers
Rossetti, A. O., & Lowenstein, D. H. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70187-9 · Cited by 341
Self-citation
Metadata
- Authors
- Rossetti, A. O., Reichhart, M. D., Schaller, M., Despland, P., & Bogousslavsky, J.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2004-06-28
- Volume
- 45
- Issue
- 7
- Pages
- 757-763
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1988502678
- Cited by
- 190
- References
- 1
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Propofol Treatment of Refractory Status Epilepticus: A Study of 31 Episodes. https://app.cochat.ai/papers/10.1111/j.0013-9580.2004.01904.x
- The paper
- Rossetti, A. O., Reichhart, M. D., Schaller, M., Despland, P., & Bogousslavsky, J. (2004). Propofol Treatment of Refractory Status Epilepticus: A Study of 31 Episodes. Epilepsia. https://doi.org/10.1111/j.0013-9580.2004.01904.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.